Search

Author/Creator Samad, Tarek A

1. Sustained reduction of serum neurofilament light chain over 7 years by alemtuzumab in early relapsing–remitting MS. (April 2022)

Authors:
Kuhle, Jens; Daizadeh, Nadia; Benkert, Pascal; Maceski, Aleksandra; Barro, Christian; Michalak, Zuzanna; Sormani, Maria Pia; Godin, Jean; Shankara, Srinivas; Samad, Tarek A; Jacobs, Alan; Chung, Luke; Rӧsch, Nora; Kaiser, Carina; Mitchell, Colin P; Leppert, David; Havari, Evis; Kappos, Ludwig
Journal:
Multiple sclerosis
Issue:
Volume 28:Number 4(2022)
Page Start:
573
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search